Robert Bernard Stockman, Director at REVA Medical, Inc. (RVA), bought 6,500 shares at $8.49 ($55K) on 2016-03-29, disclosed to the SEC on 2016-03-31.
Open-market purchase of $55k RVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| AX | BUY | 2016-07-18 | $150K | — | Filing → |
| RVA | BUY | 2016-07-18 | $150K | — | Filing → |
| RVA | BUY | 2015-06-04 | $25K | — | Filing → |